Paroxetine influences respiration in rats: implications for the treatment of panic disorder

被引:19
|
作者
Olsson, M
Annerbrink, K
Bengtsson, F
Hedner, J
Eriksson, E
机构
[1] Univ Gothenburg, Dept Pharmacol, SE-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Dept Clin Pharmacol, SE-40530 Gothenburg, Sweden
[3] Linkoping Univ Hosp, Dept Psychiat, SE-58185 Linkoping, Sweden
关键词
panic disorder; CO2; respiration; rat; hyperventilation; paroxetine; serotonin reuptake inhibitors;
D O I
10.1016/S0924-977X(03)00044-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since hyperventilation and shortness of breath are characteristic features of panic attacks, and since the attacks can be elicited by CO2 inhalation, an involvement of central or peripheral chemoreceptors in the pathophysiology of panic disorder has been suggested. Prompted by clinical reports suggesting that the susceptibility to spontaneous as well as CO2-induced anxiety and hyperventilation is attenuated by serotonin reuptake inhibitors (SRIs), we undertook the present study in order to explore the possible effect of an SRI, paroxetine, on baseline respiration and CO2-induced hyperventilation in freely moving Wistar rats. A significant increase in baseline respiratory rate was seen both after 5 and 15 weeks of treatment with paroxetine. CO2 exposure induced a dose-dependent increase in respiratory rate, but not tidal volume, in both paroxetine-treated rats and controls; this response was reduced after 15 weeks of paroxetine treatment, but not after 5 weeks of treatment. We suggest that an influence on the regulation of respiration may be of importance for the anti-panic effect of SRIs. (C) 2003 Elsevier B.V./ECNP. All rights reserved.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 50 条
  • [1] Paroxetine influences respiration in rats: Implications for the treatment of panic disorder
    Olsson, M
    Annerbrink, K
    Eriksson, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S344 - S344
  • [2] Influences of treatment with paroxetine on cholesterol levels in patients with panic disorder
    Kim, EJ
    Yu, B
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S370 - S370
  • [3] Paroxetine and respiration in panic disorder: preliminary results
    Cucchi, M
    Di Pasquale, D
    Bertani, A
    Caldirola, D
    Bellodi, L
    Perna, G
    EUROPEAN PSYCHIATRY, 2002, 17 : 164S - 164S
  • [4] Experiences with paroxetine in the treatment of panic disorder
    Lubbe, R
    NERVENHEILKUNDE, 1996, 15 (04) : 244 - 246
  • [5] Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder
    Bakker, A
    van Dyck, R
    Spinhoven, P
    van Balkom, AJLM
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (12) : 831 - 838
  • [6] A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder
    Lecrubier, Y
    Bakker, A
    Dunbar, G
    Judge, R
    ACTA PSYCHIATRICA SCANDINAVICA, 1997, 95 (02) : 145 - 152
  • [7] Serotonin influences respiratory variability in freely moving rats: Implications for panic disorder
    Annerbrink, K
    Olsson, M
    Hedner, J
    Eriksson, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S340 - S340
  • [8] Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder
    Pollack, MH
    Simon, NM
    Worthington, JJ
    Doyle, AL
    Peters, P
    Toshkov, F
    Otto, MW
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : 276 - 282
  • [9] Paroxetine in panic disorder with agoraphobia
    Pezawas, L
    Kasper, S
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2001, 5 (04) : 279 - 281
  • [10] Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder
    Annerbrink, Kristina
    Olsson, Marie
    Hedner, Jan
    Eriksson, Elias
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (12) : 1793 - 1801